Back to User profile » Dr Huaying Huang

Paper published by Dr Huaying Huang:


Significant Benefits of Afatinib and Apatinib in a Refractory Advanced NSCLC Patient Resistant to Osimertinib: A Case Report

Zhao Y, Chen Y, Huang H, Li X, Shao L, Ding H

OncoTargets and Therapy 2021, 14:3063-3067

Published Date: 7 May 2021